Effectiveness of Transcutaneous Auricular Vagus Nerve Stimulation in Bruxism
Investigation of the Effectiveness of Transcutaneous Auricular Vagus Nerve Stimulation in Bruxism- Randomised Controlled Single Blinded Study
1 other identifier
interventional
40
1 country
1
Brief Summary
Our study aimed to investigate the effects of transcutaneous auricular vagus nerve stimulation (TAVNS) application on treatment efficacy in bruxism in terms of masseter muscle activity, pain, stress level, sleep and life quality, and autonomic functions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 22, 2024
CompletedFirst Posted
Study publicly available on registry
April 26, 2024
CompletedStudy Start
First participant enrolled
May 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2024
CompletedApril 26, 2024
April 1, 2024
3 months
April 22, 2024
April 24, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Pain Severity
Participants' pain intensity will be assessed using the Visual Analog Scale, is a simple, reliable and short-term method commonly used in the clinic to measure pain intensity.The participant is told that the most severe pain he/she experiences is 10, and if he/she has no pain, the pain intensity is 0. The participant will be asked to mark a number between 0 and 10 corresponding to the intensity of pain in the masticatory muscles at rest and during chewing.
8 weeks
Oral Health Quality of Life
The Oral Health Impact Profile is revised to comprehensively measure the discomfort, disability and handicap related to oral and dental health. The scale consists of 14 questions in 7 dimensions: functional limitation, physical pain, psychological discomfort, physical disability, psychological disability, social disability and handicap. The lowest score that can be obtained from the scale is 0, while the highest score that can be obtained is 56. A high score indicates poor quality of life.
8 weeks
Stress Level
The Perceived Stress Scale-14 is a self-report scale designed to assess one's perception of the degree to which a particular situation in daily life is considered stressful. It consists of 14 items and is rated on a 4-point Likert scale ('0: never' to '4: very often'). A high total score indicates a high level of perceived stress.
8 weeks
Sleep Quality
Pittsburgh Sleep Quality Index will be used to assess the sleep quality of the participants. It assesses sleep duration, sleep disturbance, sleep efficiency, subjective sleep quality, sleep medication use, daytime work disturbance and sleep latency and consists of a total of 24 questions. The total score ranges from 0-21, with 5 and above indicating "poor sleep quality".
8 weeks
Pressure Pain Threshold
In our study, pressure pain threshold measurement of the dominant and non-dominant side masseter muscle before and after activity will be evaluated with Baseline manual algometer (2.5 kg-11 lb).
8 weeks
Muscle Activation Measurement
In our study, four-channel 'Neurotrac Myoplus Pro 4 EMG Biofeedback' device will be used for superficial EMG measurements. The EMG work-rest mode of the device will be used in the measurement and the masseter muscle activation during contraction and relaxation will be measured by asking the participant to clench his/her teeth 5 times consecutively, 5 seconds contraction time, 5 seconds relaxation time. Neurotrac PC Software program will be used for electromyographic analysis during the measurement.
8 weeks
Measurement of heart rate variability/ Autonomic nervous system evaluation
All participants included in the study will undergo a 5-minute heart rate variability measurement test with the Polar H10 chest strap device. The data obtained after the measurement will be analyzed with Kubios program. Stress index (cardiovascular system stress), PNS index (parasympathetic nervous system dominance), SNS index (sympathetic nervous system dominance), LF power (sympathetic activity) and HF power (parasympathetic activity) parameters will be recorded in Kubios program.
8 weeks
Study Arms (2)
TAVNS group
EXPERIMENTALExercise group
OTHERInterventions
TAVNS is a recently introduced treatment involving transcutaneous electrical stimulation of the auricular branch of the vagus nerve with VAGUSTIM device.
Rocabado 6x6 exercises will be applied in our study. Rocabado exercise, which is the most commonly used exercise method in the literature, is a set of exercises for the craniocervical and craniomandibular system.
Eligibility Criteria
You may qualify if:
- Diagnosed with bruxism between the ages of 18-65,
- A history of bruxism for at least 6 months,
- Individuals with masseter muscle pain GAS≥4 at rest and during mastication
You may not qualify if:
- Masseter botox application in the last 6 months,
- Regular use of analgesics and anti-inflammatories that affect the OSS,
- Presence of infection or tumoral structures within intraoral structures,
- Wearing multiple ear piercings,
- With TMJ disc displacement and joint degeneration,
- Musculoskeletal problem with evidence of cervical or TMJ fracture, systemic disease, specific pathologic condition,
- Any surgical operation related to a cervical or TMJ problem,
- Less than 6 months of cervical or TMJ-related physiotherapy and rehabilitation services,
- The one with facial paralysis,
- Diagnosed psychiatric illness
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bandırma Onyedi Eylül University
Balıkesir, Turkey (Türkiye)
Related Publications (1)
Guzel HC, Turkmen OB, Mutlu EK, Turkmen G, Sakar O, Ormeci GO. Effectiveness of Transcutaneous Auricular Vagus Nerve Stimulation in Bruxism: A Randomised, Controlled, Single-Blind Experimental Trial. J Oral Rehabil. 2026 Feb;53(2):493-504. doi: 10.1111/joor.70096. Epub 2025 Nov 10.
PMID: 41211817DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assist. Prof. Dr
Study Record Dates
First Submitted
April 22, 2024
First Posted
April 26, 2024
Study Start
May 1, 2024
Primary Completion
August 1, 2024
Study Completion
November 1, 2024
Last Updated
April 26, 2024
Record last verified: 2024-04